Another investigation revealed that when a mouse tumor model was treated with genetically modified lactic acid bacteria designed to generate IL-10 or antioxidant enzymes, the CRC tumor development was inhibited [45], demonstrating that IL-10 might limit tumor progression. Here, IL10 is linked to colorectal carcinoma.